US to revise Covid vaccine guidance after allergic reactions

The US Food and Drug Administration (FDA) said Thursday it was working with Pfizer to revise a fact sheet for recipients of the Pfizer-BioNTech Covid-19 vaccine after two people had allergic reactions.